CAJ | 학술논문

目的观察肌电生物反馈治疗脑卒中后吞咽障碍的临床疗效.方法采用随机数字表法将脑卒中后吞咽障碍患者分为对照组、电刺激组及肌电生物反馈组.对照组患者给予单纯吞咽功能训练,电刺激组及肌电生物反馈组在常规吞咽训练基础上分别给予电刺激或肌电生物反馈治疗,每周治疗5次,共持续治疗3周.于治疗前、治疗3周后分别采用表面肌电图(sEMG)和标准吞咽功能评估法(SSA)对各组患者吞咽功能进行评定.结果 3组患者分别经3周治疗后,发现其sEMG平均波幅、吞咽时限及SSA评分均较治疗前明显改善(P＜0.05);并且肌电生物反馈组及电刺激组sEMG平均波幅[分别为(25.96±2.49) μV和(22.71 ±4.29) μV]、吞咽时限[分别为(1.15±0.11)s和(1.25±0.11)s]及SSA评分[分别为(22.40±3.46)分和(27.39 ±4.58)分]均显著优于对照组(P＜0.05);同时肌电生物反馈组上述疗效指标亦显著优于电刺激组(P＜0.05).结论肌电生物反馈治疗可显著改善脑卒中患者吞咽功能,其疗效明显优于电刺激及单纯吞咽功能训练.
목적 관찰기전생물반궤치료뇌졸중후탄인장애적림상료효.방법 채용수궤수자표법장뇌졸중후탄인장애환자분위대조조、전자격조급기전생물반궤조.대조조환자급여단순탄인공능훈련,전자격조급기전생물반궤조재상규탄인훈련기출상분별급여전자격혹기전생물반궤치료,매주치료5차,공지속치료3주.우치료전、치료3주후분별채용표면기전도(sEMG)화표준탄인공능평고법(SSA)대각조환자탄인공능진행평정.결과 3조환자분별경3주치료후,발현기sEMG평균파폭、탄인시한급SSA평분균교치료전명현개선(P＜0.05);병차기전생물반궤조급전자격조sEMG평균파폭[분별위(25.96±2.49) μV화(22.71 ±4.29) μV]、탄인시한[분별위(1.15±0.11)s화(1.25±0.11)s]급SSA평분[분별위(22.40±3.46)분화(27.39 ±4.58)분]균현저우우대조조(P＜0.05);동시기전생물반궤조상술료효지표역현저우우전자격조(P＜0.05).결론 기전생물반궤치료가현저개선뇌졸중환자탄인공능,기료효명현우우전자격급단순탄인공능훈련.
Objective To investigate the efficacy of electromyographic biofeedback therapy (EMGBFT) in treating dysphagia after stroke.Methods Patients diagnosed with dysphagia after stroke were recruited and randomly divided into a control group (n =22),an electrostimulation group (ES,n =25) and an EMGBFT group (n =23).The control group received conventional treatment,while the patients in the other groups additionally received Vitalstim ES or EMGBFT 5 times per week for 3 weeks.Before and after the trial,deglutition function was evaluated through surface electromyography (sEMG) and using a standardized swallowing assessment (SSA).Results After 3 weeks of treatment,the mean sEMG amplitude,deglutition duration and SSA score and improved significantly in comparison to the baseline in all three groups.All were also significantly better in the two treatment groups than in the control group.Importantly,the mean sEMG amplitude,deglutition duration and SSA score were all significantly better in the EMGBFT group than in the ES group.Conclusion EMGBFT can promote better deglutition among patients with dysphagia after stroke more effectively than ES or conventional treatment.